Request for Covid-19 Impact Assessment of this Report
The United States Crizotinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Crizotinib market, reaching US$ million by the year 2028. As for the Europe Crizotinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Crizotinib players cover Pfizer, Beacon Pharma, Incepta Pharmaceuticals, and Drug International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Crizotinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
250mg*60 Capsules
200mg*60 Capsules
250mg*28 Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
ALK Positive NSCLC
ROS1 Positive NSCLC
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Beacon Pharma
Incepta Pharmaceuticals
Drug International
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Crizotinib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Crizotinib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Crizotinib by Country/Region, 2017, 2022 & 2028
2.2 Crizotinib Segment by Type
2.2.1 250mg*60 Capsules
2.2.2 200mg*60 Capsules
2.2.3 250mg*28 Capsules
2.3 Crizotinib Sales by Type
2.3.1 Global Crizotinib Sales Market Share by Type (2017-2022)
2.3.2 Global Crizotinib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Crizotinib Sale Price by Type (2017-2022)
2.4 Crizotinib Segment by Application
2.4.1 ALK Positive NSCLC
2.4.2 ROS1 Positive NSCLC
2.5 Crizotinib Sales by Application
2.5.1 Global Crizotinib Sale Market Share by Application (2017-2022)
2.5.2 Global Crizotinib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Crizotinib Sale Price by Application (2017-2022)
3 Global Crizotinib by Company
3.1 Global Crizotinib Breakdown Data by Company
3.1.1 Global Crizotinib Annual Sales by Company (2020-2022)
3.1.2 Global Crizotinib Sales Market Share by Company (2020-2022)
3.2 Global Crizotinib Annual Revenue by Company (2020-2022)
3.2.1 Global Crizotinib Revenue by Company (2020-2022)
3.2.2 Global Crizotinib Revenue Market Share by Company (2020-2022)
3.3 Global Crizotinib Sale Price by Company
3.4 Key Manufacturers Crizotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crizotinib Product Location Distribution
3.4.2 Players Crizotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Crizotinib by Geographic Region
4.1 World Historic Crizotinib Market Size by Geographic Region (2017-2022)
4.1.1 Global Crizotinib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Crizotinib Annual Revenue by Geographic Region
4.2 World Historic Crizotinib Market Size by Country/Region (2017-2022)
4.2.1 Global Crizotinib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Crizotinib Annual Revenue by Country/Region
4.3 Americas Crizotinib Sales Growth
4.4 APAC Crizotinib Sales Growth
4.5 Europe Crizotinib Sales Growth
4.6 Middle East & Africa Crizotinib Sales Growth
5 Americas
5.1 Americas Crizotinib Sales by Country
5.1.1 Americas Crizotinib Sales by Country (2017-2022)
5.1.2 Americas Crizotinib Revenue by Country (2017-2022)
5.2 Americas Crizotinib Sales by Type
5.3 Americas Crizotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crizotinib Sales by Region
6.1.1 APAC Crizotinib Sales by Region (2017-2022)
6.1.2 APAC Crizotinib Revenue by Region (2017-2022)
6.2 APAC Crizotinib Sales by Type
6.3 APAC Crizotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Crizotinib by Country
7.1.1 Europe Crizotinib Sales by Country (2017-2022)
7.1.2 Europe Crizotinib Revenue by Country (2017-2022)
7.2 Europe Crizotinib Sales by Type
7.3 Europe Crizotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Crizotinib by Country
8.1.1 Middle East & Africa Crizotinib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Crizotinib Revenue by Country (2017-2022)
8.2 Middle East & Africa Crizotinib Sales by Type
8.3 Middle East & Africa Crizotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crizotinib
10.3 Manufacturing Process Analysis of Crizotinib
10.4 Industry Chain Structure of Crizotinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crizotinib Distributors
11.3 Crizotinib Customer
12 World Forecast Review for Crizotinib by Geographic Region
12.1 Global Crizotinib Market Size Forecast by Region
12.1.1 Global Crizotinib Forecast by Region (2023-2028)
12.1.2 Global Crizotinib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Crizotinib Forecast by Type
12.7 Global Crizotinib Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Crizotinib Product Offered
13.1.3 Pfizer Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Beacon Pharma
13.2.1 Beacon Pharma Company Information
13.2.2 Beacon Pharma Crizotinib Product Offered
13.2.3 Beacon Pharma Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Beacon Pharma Main Business Overview
13.2.5 Beacon Pharma Latest Developments
13.3 Incepta Pharmaceuticals
13.3.1 Incepta Pharmaceuticals Company Information
13.3.2 Incepta Pharmaceuticals Crizotinib Product Offered
13.3.3 Incepta Pharmaceuticals Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Incepta Pharmaceuticals Main Business Overview
13.3.5 Incepta Pharmaceuticals Latest Developments
13.4 Drug International
13.4.1 Drug International Company Information
13.4.2 Drug International Crizotinib Product Offered
13.4.3 Drug International Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Drug International Main Business Overview
13.4.5 Drug International Latest Developments
14 Research Findings and Conclusion
Table 1. Crizotinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Crizotinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 250mg*60 Capsules
Table 4. Major Players of 200mg*60 Capsules
Table 5. Major Players of 250mg*28 Capsules
Table 6. Global Crizotinib Sales by Type (2017-2022) & (K Pcs)
Table 7. Global Crizotinib Sales Market Share by Type (2017-2022)
Table 8. Global Crizotinib Revenue by Type (2017-2022) & ($ million)
Table 9. Global Crizotinib Revenue Market Share by Type (2017-2022)
Table 10. Global Crizotinib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 11. Global Crizotinib Sales by Application (2017-2022) & (K Pcs)
Table 12. Global Crizotinib Sales Market Share by Application (2017-2022)
Table 13. Global Crizotinib Revenue by Application (2017-2022)
Table 14. Global Crizotinib Revenue Market Share by Application (2017-2022)
Table 15. Global Crizotinib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 16. Global Crizotinib Sales by Company (2020-2022) & (K Pcs)
Table 17. Global Crizotinib Sales Market Share by Company (2020-2022)
Table 18. Global Crizotinib Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Crizotinib Revenue Market Share by Company (2020-2022)
Table 20. Global Crizotinib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 21. Key Manufacturers Crizotinib Producing Area Distribution and Sales Area
Table 22. Players Crizotinib Products Offered
Table 23. Crizotinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Crizotinib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 27. Global Crizotinib Sales Market Share Geographic Region (2017-2022)
Table 28. Global Crizotinib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Crizotinib Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Crizotinib Sales by Country/Region (2017-2022) & (K Pcs)
Table 31. Global Crizotinib Sales Market Share by Country/Region (2017-2022)
Table 32. Global Crizotinib Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Crizotinib Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Crizotinib Sales by Country (2017-2022) & (K Pcs)
Table 35. Americas Crizotinib Sales Market Share by Country (2017-2022)
Table 36. Americas Crizotinib Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Crizotinib Revenue Market Share by Country (2017-2022)
Table 38. Americas Crizotinib Sales by Type (2017-2022) & (K Pcs)
Table 39. Americas Crizotinib Sales Market Share by Type (2017-2022)
Table 40. Americas Crizotinib Sales by Application (2017-2022) & (K Pcs)
Table 41. Americas Crizotinib Sales Market Share by Application (2017-2022)
Table 42. APAC Crizotinib Sales by Region (2017-2022) & (K Pcs)
Table 43. APAC Crizotinib Sales Market Share by Region (2017-2022)
Table 44. APAC Crizotinib Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Crizotinib Revenue Market Share by Region (2017-2022)
Table 46. APAC Crizotinib Sales by Type (2017-2022) & (K Pcs)
Table 47. APAC Crizotinib Sales Market Share by Type (2017-2022)
Table 48. APAC Crizotinib Sales by Application (2017-2022) & (K Pcs)
Table 49. APAC Crizotinib Sales Market Share by Application (2017-2022)
Table 50. Europe Crizotinib Sales by Country (2017-2022) & (K Pcs)
Table 51. Europe Crizotinib Sales Market Share by Country (2017-2022)
Table 52. Europe Crizotinib Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Crizotinib Revenue Market Share by Country (2017-2022)
Table 54. Europe Crizotinib Sales by Type (2017-2022) & (K Pcs)
Table 55. Europe Crizotinib Sales Market Share by Type (2017-2022)
Table 56. Europe Crizotinib Sales by Application (2017-2022) & (K Pcs)
Table 57. Europe Crizotinib Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Crizotinib Sales by Country (2017-2022) & (K Pcs)
Table 59. Middle East & Africa Crizotinib Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Crizotinib Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Crizotinib Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Crizotinib Sales by Type (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Crizotinib Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Crizotinib Sales by Application (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Crizotinib Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Crizotinib
Table 67. Key Market Challenges & Risks of Crizotinib
Table 68. Key Industry Trends of Crizotinib
Table 69. Crizotinib Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Crizotinib Distributors List
Table 72. Crizotinib Customer List
Table 73. Global Crizotinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 74. Global Crizotinib Sales Market Forecast by Region
Table 75. Global Crizotinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Crizotinib Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 78. Americas Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Crizotinib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 80. APAC Crizotinib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Europe Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Crizotinib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 86. Global Crizotinib Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Crizotinib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Crizotinib Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Crizotinib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 90. Global Crizotinib Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Crizotinib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Crizotinib Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Crizotinib Product Offered
Table 95. Pfizer Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Beacon Pharma Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors
Table 99. Beacon Pharma Crizotinib Product Offered
Table 100. Beacon Pharma Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Beacon Pharma Main Business
Table 102. Beacon Pharma Latest Developments
Table 103. Incepta Pharmaceuticals Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors
Table 104. Incepta Pharmaceuticals Crizotinib Product Offered
Table 105. Incepta Pharmaceuticals Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Incepta Pharmaceuticals Main Business
Table 107. Incepta Pharmaceuticals Latest Developments
Table 108. Drug International Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors
Table 109. Drug International Crizotinib Product Offered
Table 110. Drug International Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Drug International Main Business
Table 112. Drug International Latest Developments
List of Figures
Figure 1. Picture of Crizotinib
Figure 2. Crizotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crizotinib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Crizotinib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Crizotinib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 250mg*60 Capsules
Figure 10. Product Picture of 200mg*60 Capsules
Figure 11. Product Picture of 250mg*28 Capsules
Figure 12. Global Crizotinib Sales Market Share by Type in 2021
Figure 13. Global Crizotinib Revenue Market Share by Type (2017-2022)
Figure 14. Crizotinib Consumed in ALK Positive NSCLC
Figure 15. Global Crizotinib Market: ALK Positive NSCLC (2017-2022) & (K Pcs)
Figure 16. Crizotinib Consumed in ROS1 Positive NSCLC
Figure 17. Global Crizotinib Market: ROS1 Positive NSCLC (2017-2022) & (K Pcs)
Figure 18. Global Crizotinib Sales Market Share by Application (2017-2022)
Figure 19. Global Crizotinib Revenue Market Share by Application in 2021
Figure 20. Crizotinib Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Crizotinib Revenue Market Share by Company in 2021
Figure 22. Global Crizotinib Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Crizotinib Revenue Market Share by Geographic Region in 2021
Figure 24. Global Crizotinib Sales Market Share by Region (2017-2022)
Figure 25. Global Crizotinib Revenue Market Share by Country/Region in 2021
Figure 26. Americas Crizotinib Sales 2017-2022 (K Pcs)
Figure 27. Americas Crizotinib Revenue 2017-2022 ($ Millions)
Figure 28. APAC Crizotinib Sales 2017-2022 (K Pcs)
Figure 29. APAC Crizotinib Revenue 2017-2022 ($ Millions)
Figure 30. Europe Crizotinib Sales 2017-2022 (K Pcs)
Figure 31. Europe Crizotinib Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Crizotinib Sales 2017-2022 (K Pcs)
Figure 33. Middle East & Africa Crizotinib Revenue 2017-2022 ($ Millions)
Figure 34. Americas Crizotinib Sales Market Share by Country in 2021
Figure 35. Americas Crizotinib Revenue Market Share by Country in 2021
Figure 36. United States Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Crizotinib Sales Market Share by Region in 2021
Figure 41. APAC Crizotinib Revenue Market Share by Regions in 2021
Figure 42. China Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Crizotinib Sales Market Share by Country in 2021
Figure 49. Europe Crizotinib Revenue Market Share by Country in 2021
Figure 50. Germany Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Crizotinib Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Crizotinib Revenue Market Share by Country in 2021
Figure 57. Egypt Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Crizotinib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Crizotinib in 2021
Figure 63. Manufacturing Process Analysis of Crizotinib
Figure 64. Industry Chain Structure of Crizotinib
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...